Zhang J, She D Y, Feng D, et al. Dynamic changes of serum soluble triggering receptorexpressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study[J]. BMC Infect Dis,2011,11:53.
[2]
Zhang J, She D Y, Feng D, et al. Dynamic changes of serum soluble triggering receptorexpressed on myeloid cells-1 (sTREM-1) reflect sepsis severity and can predict prognosis: a prospective study[J]. BMC Infect Dis,2011,11:53.
[3]
Wang H J, Meng K, Chen W J, et al. Serum miR-574-5p: a prognostic predictor of sepsis patients[J]. SHOCK,2012,37(3):263-267.
[3]
Wang H J, Meng K, Chen W J, et al. Serum miR-574-5p: a prognostic predictor of sepsis patients[J]. SHOCK,2012,37(3):263-267.
[4]
Wang H J, Zhang P J, Chen W J, et al.Serum MicroRNA Signatures Identified by Solexa Sequencing Predict Sepsis Patients Mortality: A Prospective Observational Study[J]. PLoS ONE,2012,7(6): e38885.
[4]
Wang H J, Zhang P J, Chen W J, et al.Serum MicroRNA Signatures Identified by Solexa Sequencing Predict Sepsis Patients Mortality: A Prospective Observational Study[J]. PLoS ONE,2012,7(6): e38885.
[5]
Pierrakos C, Vincent J L. Sepsis biomarkers: a review[J]. Crit Care. 2010,14(1):R15.
[5]
Pierrakos C, Vincent J L. Sepsis biomarkers: a review[J]. Crit Care. 2010,14(1):R15.
[6]
Su L X, Han B C, Liu C T, et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study[J]. BMC Infect Dis,2012,12:157.
[6]
Su L X, Han B C, Liu C T, et al. Value of soluble TREM-1, procalcitonin, and C-reactive protein serum levels as biomarkers for detecting bacteremia among sepsis patients with new fever in intensive care units: a prospective cohort study[J]. BMC Infect Dis,2012,12:157.
[7]
Su L X, Meng K, Zhang X, et al. Diagnostic Value of sTREM-1 and Procalcitonin Serum Levels and Pulmonary Infection Score for Ventilator-associated Pneumonia among ICU Sepsis Patients[J]. AM J CRIT CARE, 2012,21(6):e110-e119..
[7]
Su L X, Meng K, Zhang X, et al. Diagnostic Value of sTREM-1 and Procalcitonin Serum Levels and Pulmonary Infection Score for Ventilator-associated Pneumonia among ICU Sepsis Patients[J]. AM J CRIT CARE, 2012,21(6):e110-e119..
[8]
Su L X, Feng L, Zhang J, et al. Diagnostic Value of Urine sTREM-1 for Sepsis & Relevant Acute Kidney Injuries: a prospective study[J]. Crit Care,2011,15:R250.
[8]
Su L X, Feng L, Zhang J, et al. Diagnostic Value of Urine sTREM-1 for Sepsis & Relevant Acute Kidney Injuries: a prospective study[J]. Crit Care,2011,15:R250.
[9]
Su L X, Liu C T, Li C, et al. Dynamic Changes in Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and its Gene Polymorphisms are Associated with Sepsis Prognosis[J]. Inflammation. 2012,14:235-238.
[9]
Su L X, Liu C T, Li C, et al. Dynamic Changes in Serum Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) and its Gene Polymorphisms are Associated with Sepsis Prognosis[J]. Inflammation. 2012,14:235-238.
[10]
冯 林. sCD163在脓毒症中的应用[D].天津:南开大学,2011.
[10]
冯 林. sCD163在脓毒症中的应用[D].天津:南开大学,2011.
[11]
Feng L, Zhou X, Su L X, et al. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study[J]. PLoS ONE,2012,7(7): e38400.
[11]
Feng L, Zhou X, Su L X, et al. Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study[J]. PLoS ONE,2012,7(7): e38400.
[12]
Su LX, Feng L, Liu C T, et al. Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study[J]. BMC Nephrology,2012,13(1):123.
[12]
Su LX, Feng L, Liu C T, et al. Diagnostic value of urine sCD163 levels for sepsis and relevant acute kidney injury: a prospective study[J]. BMC Nephrology,2012,13(1):123.
Wang H, Zhang P, Chen W, et al. Evidence for serum mir-15a and mir-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects[J]. Clinical chemistry and laboratory medicine : CCLM / FESCC,2012,50:1423-1428.
[14]
Wang H, Zhang P, Chen W, et al. Evidence for serum mir-15a and mir-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects[J]. Clinical chemistry and laboratory medicine : CCLM / FESCC,2012,50:1423-1428.
[15]
Wu L, Li H, Jia C Y, et al. Microrna-223 regulates foxo1 expression and cell proliferation[J]. FEBS letters,2012,586:1038-1043.
[15]
Wu L, Li H, Jia C Y, et al. Microrna-223 regulates foxo1 expression and cell proliferation[J]. FEBS letters,2012,586:1038-1043.
[16]
Ricci Z, Ronco C.Pathogenesis of acute kidney injury during sepsis[J]. Curr Drug Targets,2009,10:1179-1183.
[16]
Ricci Z, Ronco C.Pathogenesis of acute kidney injury during sepsis[J]. Curr Drug Targets,2009,10:1179-1183.
[17]
Vincent J L. Acute kidney injury, acute lung injury and septic shock: how does mortality compare[J]? Contrib Nephrol,2011,174: 71-77.
[18]
Su L, Zhou R, Liu C, et al. Urinary proteomics analysis for sepsis biomarkers with iTRAQ labeling and two-dimensional liquid chromatography-tandem mass spectrometry[J]. Journal of trauma and acute care surgery,2013,74(3):940-945.
[17]
Vincent J L. Acute kidney injury, acute lung injury and septic shock: how does mortality compare[J]? Contrib Nephrol,2011,174: 71-77.
[18]
Su L, Zhou R, Liu C, et al. Urinary proteomics analysis for sepsis biomarkers with iTRAQ labeling and two-dimensional liquid chromatography-tandem mass spectrometry[J]. Journal of trauma and acute care surgery,2013,74(3):940-945.
[19]
Su L, Cao L, Zhou R, et al. Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS[J].PLoS ONE,2013,8(1):e54237.
[20]
Sanchez F A,Tian J,Picarella D,et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance[J]. Nature immunology,2003,4(11):1093-1101.
[19]
Su L, Cao L, Zhou R, et al. Identification of novel biomarkers for sepsis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS[J].PLoS ONE,2013,8(1):e54237.
[20]
Sanchez F A,Tian J,Picarella D,et al. Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance[J]. Nature immunology,2003,4(11):1093-1101.
[21]
Chiba S,Baghdadi M,Akiba H,et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1[J]. Nature immunology 2012,13(9):832-842.
[21]
Chiba S,Baghdadi M,Akiba H,et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1[J]. Nature immunology 2012,13(9):832-842.
[22]
Hastings W D,Anderson D E,Kassam N,et al. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines[J].European journal of immunology,2009,39(9):2492-2501.
[22]
Hastings W D,Anderson D E,Kassam N,et al. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines[J].European journal of immunology,2009,39(9):2492-2501.
[23]
Yang X,Jiang X,Chen G,et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response[J]. J Immunol,2013,190(5):2068-2079.
[23]
Yang X,Jiang X,Chen G,et al. T cell Ig mucin-3 promotes homeostasis of sepsis by negatively regulating the TLR response[J]. J Immunol,2013,190(5):2068-2079.
2013, Vol. 24 
